Bortezomib for patients with previously untreated multiple myeloma: a systematic review and meta-analysis of randomized controlled trials

@article{Zeng2013BortezomibFP,
  title={Bortezomib for patients with previously untreated multiple myeloma: a systematic review and meta-analysis of randomized controlled trials},
  author={Zhi-yong Zeng and Junfang Lin and Junmin Chen},
  journal={Annals of Hematology},
  year={2013},
  volume={92},
  pages={935-943}
}
Multiple myeloma (MM) is an incurable disease with a poor survival, which has not been affected even by high-dose chemotherapy. This systematic review was performed to assess the efficacy and safety of the novel agent bortezomib for patients with previously untreated MM. We systematically searched biomedical literature databases and identified randomized… CONTINUE READING